The Role of LRRK2 in Neurodegeneration of Parkinson Disease

Current Neuropharmacology
Qin RuiGang Chen

Abstract

The leucine-rich repeat kinase 2 (LRRK2) gene and α-synuclein gene (SNCA) are the key influencing factors of Parkinson's disease (PD). It is reported that dysfunction of LRRK2 may influence the accumulation of α-synuclein and its pathology to alter cellular functions and signaling pathways by the kinase activation of LRRK2. The accumulation of α-synuclein is one of the main stimulants of microglial activation. Microglia are macrophages that reside in the brain, and activation of microglia is believed to contribute to neuroinflammation and neuronal death in PD. Therefore, clarifying the complex relationship among LRRK2, α-synuclein and microglials could offer targeted clinical therapies for PD. Here, we provide an updated review focused on the discussion of the evidence supporting some of the key mechanisms that are important for LRRK2-dependent neurodegeneration in PD.

Citations

Jun 26, 2020·Diseases·Neha JoshiShirisha Nagotu
Jun 2, 2020·Frontiers in Aging Neuroscience·Yunying Yang, Zhentao Zhang
Apr 24, 2020·Cellular and Molecular Neurobiology·Jenny SassoneBarbara Garavaglia
Jul 12, 2020·Antioxidants·Kuo-Hsuan Chang, Chiung-Mei Chen
Jan 11, 2020·Frontiers in Neurology·Alexander KilzheimerJulia M Schulze-Hentrich
Jul 30, 2020·International Journal of Molecular Sciences·Renata Zawirska-WojtasiakEliza Wyszko
Sep 24, 2020·Journal of Neurochemistry·Melina OverhoffNatalia L Kononenko
Aug 28, 2020·Neurochemistry International·Dia AdvaniPravir Kumar
Apr 4, 2021·International Journal of Molecular Sciences·Jinsha LiuSepideh Afshar
Jun 8, 2021·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Sarah Sohyun ParkAna C Andreazza

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
environmental stresses

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.